Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A Musculoskeletal Simulation Framework for In Silico Design and Optimization of a Soft Exosuit for Children with Muscular Dystrophy

Award Number: R43TR003959
ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/15/2021
PERIOD OF PERFORMANCE END DATE: 07/14/2022

Group Awards By:

View Award Description

A Musculoskeletal Simulation Framework for In Silico Design and Optimization of a Soft Exosuit for Children with Muscular Dystrophy - PROJECT SUMMARY/ABSTRACT Muscular dystrophies (MD), such as Duchenne MD and Becker MD, are rare genetic diseases that cause progressive muscle degeneration in approximately 14 in 100,000 males ages 5-24. Currently there is no known treatment that can stop or reverse the damage caused by MD. Dystrophic muscle is especially susceptible to damage during eccentric contraction. Soft exosuits are an emerging class of wearable device that may be able to reduce eccentric contraction during functional movements such as downhill walking, which requires substantial eccentric knee extensor contraction. Exosuits utilize compliant textile-based actuators to inherently provide safety and comfort to the user, which is highly desirable for avoiding excessive muscle injury in boys with MD. However, one potential barrier to development of exosuits for boys with MD is the risk of injury during human subjects testing of new prototypes. Musculoskeletal simulations are an ideal tool for early-stage design of exosuits for children with MD because simulations provide characterization of muscle eccentric contraction, which is difficult to observe experimentally, and avoid risk of injury to human subjects when testing prototypes. Thus, the overall objective of this project is to develop a musculoskeletal simulation framework for in silico design and optimization of a soft exosuit for children with MD. First, existing simulations of healthy adults walking downhill will be modified to include a simulated soft exosuit. The initial exosuit design will be based on existing physical prototypes. A novel optimization framework will be used to optimize the exosuit to minimize eccentric contraction in the rectus femoris (a knee extensor) during downhill walking. Statistical analysis will be performed to test the hypotheses that (1) simulated eccentric contraction (i.e., net negative work) in the rectus femoris is significantly reduced by the exosuit and (2) eccentric contraction is further reduced following optimization. In addition, changes in joint reaction forces and eccentric contraction in other muscles will be quantified to investigate potential adverse side effects. After establishing potential benefits of the exosuit using the adult model, a musculoskeletal model of a child will be developed. A simulated isometric task will be used to calibrate maximum isometric muscle force in a typically developing and MD child model to match published strength data. Preliminary simulations of a child walking downhill with the exosuit will be generated by scaling the adult movement data using a retargeting algorithm. The exosuit optimization framework will be applied to both the typically developing child and child with MD models to determine whether the optimized exosuit provided a sufficient reduction in rectus femoris eccentric contraction to be statistically significant in future human subjects experiments. The proposed research aims to establish a foundation for design of an exosuit that can substantially improve quality of life for children with MD in the near term. In addition, the musculoskeletal simulation-based design optimization framework will facilitate rapid in silico design and testing of assistive devices, such as soft exosuits, without risk to human subjects.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = -$208 )
2023	2021	CFD RESEARCH CORPORATION	6820 MOQUIN DR NW	HUNTSVILLE	AL	35806	MADISON	USA	National Center for Advancing Translational Sciences	000	1	2/14/2023	NEW	-$208
														Subtotal = -$208

Issue Date FY: 2021 ( Subtotal = $253,606 )
2021	2021	CFD RESEARCH CORPORATION	6820 MOQUIN DR NW	HUNTSVILLE	AL	35806	MADISON	USA	National Center for Advancing Translational Sciences	000	1	7/14/2021	NEW	$253,606
														Subtotal = $253,606

Grand Total All Awards = $253,398

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Musculoskeletal Simulation Framework for In Silico Design and Optimization of a Soft Exosuit for Children with Muscular Dystrophy

Award Number: R43TR003959

ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/15/2021

PERIOD OF PERFORMANCE END DATE: 07/14/2022

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer